HQ Function

The headquarters serves as the primary center for Prelude Therapeutics' research and development activities, clinical operations, corporate administration, and strategic leadership.

Notable Features:

The facility is part of a redeveloped life sciences campus, featuring modern laboratory spaces and offices designed to support cutting-edge biopharmaceutical research and drug development.

Work Culture:

Prelude fosters a dynamic, science-driven work culture focused on innovation, collaboration, and a strong commitment to patients. The environment encourages rigorous scientific inquiry and a sense of urgency in developing new cancer treatments.

HQ Significance:

Located in the Delaware biotechnology hub, the headquarters benefits from access to a skilled talent pool, proximity to research institutions, and a supportive ecosystem for life sciences companies. This strategic location aids its research and collaboration efforts.

Values Reflected in HQ: The headquarters' focus on advanced research facilities and a collaborative environment reflects Prelude's core values of scientific excellence, innovation, integrity, and a patient-centric approach to drug discovery.

Location:

While Prelude Therapeutics is headquartered in the United States, its clinical development programs often involve trial sites across multiple countries, indicating a global research footprint. The company's strategic vision includes seeking regulatory approvals and making its therapies available to patients worldwide, if successfully developed and approved. Although direct physical office locations are primarily U.S.-based, functions such as clinical operations, regulatory affairs, and potential partnerships support a global outlook.

Street Address:

200 Powder Mill Road

City:

Wilmington

State/Province:

Delaware

Country:

USA